Cognitive Behavior Therapy for Anxiety-related Asthma in Adults.
1 other identifier
interventional
6
1 country
1
Brief Summary
This is a study to develop a protocol on Cognitive behavior therapy (CBT) for asthma-related anxiety that in a consecutive study can be translated to internet-delivered CBT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable asthma
Started Aug 2017
Shorter than P25 for not_applicable asthma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2017
CompletedFirst Posted
Study publicly available on registry
May 18, 2017
CompletedStudy Start
First participant enrolled
August 16, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 7, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 7, 2018
CompletedMarch 8, 2018
March 1, 2018
7 months
May 16, 2017
March 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Penn State Worry Questionnaire
Change in subjective worry measured with a self-rating scale weekly during 1-3 weeks at baseline and at 10 to 12 weeks post treatment for analysis of effect.
Baseline to 12 weeks
Secondary Outcomes (7)
Anxiety Sensitivity Index-3
Baseline to 12 weeks
Short Health Anxiety Inventory (SHAI)
Baseline to 12 weeks
Asthma Quality of Life Questionnaire
Baseline to 12 weeks
Asthma control test
Baseline to 12 weeks
Catastrophizing about asthma Scale
Baseline to 12 weeks
- +2 more secondary outcomes
Study Arms (1)
CBT for anxiety-related asthma
EXPERIMENTALTen to twelve weekly sessions of CBT targeting enhanced function and decreased symptoms of anxiety.
Interventions
The specific assignments in the intervention will be based on individual behavior analysis for each participant.
Eligibility Criteria
You may qualify if:
- asthma diagnosed by a physician
- anxiety or stress related to asthma
You may not qualify if:
- severe psychiatric disorder (e.g. psychotic disorder, addiction disorder, suicidal ideation).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
Stockholm, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Catarina Almqvist Malmros, MD, PhD
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 16, 2017
First Posted
May 18, 2017
Study Start
August 16, 2017
Primary Completion
March 7, 2018
Study Completion
March 7, 2018
Last Updated
March 8, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share